UNSPSC 51385807: Piroxicam cinnamate

This classification denotes a cyclooxygenase inhibitor with the molecular formula C24H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E8Q32N75N, chemically known as 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide, cinnamate (ester) but more generally known as piroxicam cinnamate, which bears US NIH Compound Identifier 6436090. European Medicines Agency schedules Piroxicam cinnamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14900MIG.

UNSPSC 51385807 Piroxicam cinnamate is a Commodity code that tracks pharmaceutical topical anti-inflammatory agents used in state and local health and welfare programs. The code shows minimal recent state and local procurement activity; the single sourced opportunity does not involve piroxicam cinnamate directly but instead reflects broader county health procurement under pharmaceutical-adjacent codes, indicating that this specific active pharmaceutical ingredient sees little targeted purchasing at the state and local level.

Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, to procure naloxone and drug deactivation systems for community health initiatives, with a response deadline of July 26, 2023. The solicitation demonstrates county acquisition of pharmaceutical and medical supplies through competitive bidding, though the specific commodity (naloxone and deactivation systems rather than piroxicam cinnamate) indicates that state and local health purchasing under this UNSPSC code does not align closely with recent solicitation patterns. Without additional opportunities reflecting direct procurement of piroxicam cinnamate formulations by state departments, counties, or health districts, no clear geographic concentration or issuing-body pattern emerges for this code.